Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 38:1554-1563
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tahara, S.
Right arrow Articles by Ogawa, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tahara, S.
Right arrow Articles by Ogawa, S.

EXPERIMENTAL STUDY

Potassium channel blocker activates extracellular signal-regulated kinases through Pyk2 and epidermal growth factor receptor in rat cardiomyocytes

Satoko Tahara, MD*, Keiichi Fukuda, MD, PhD*,{dagger}, Hiroaki Kodama, MD*, Takahiro Kato, MD*, Shunichiro Miyoshi, MD, PhD{ddagger} and Satoshi Ogawa, MD, PhD*

* Cardiopulmonary Division, Department of Internal Medicine, Tokyo, Japan
{dagger} Institute for Advanced Cardiac Therapeutics, Tokyo, Japan
{ddagger} Department of Physiology, Keio University School of Medicine, Tokyo, Japan

Manuscript received November 29, 2000; revised manuscript received June 27, 2001, accepted July 19, 2001.

* Reprint requests and correspondence: Dr. Keiichi Fukuda, Institute for Advanced Cardiac Therapeutics, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
kfukuda{at}mc.med.keio.ac.jp

OBJECTIVES

We sought to determine whether potassium (K+) channel blockers (KBs) can activate extracellular signal-regulated kinase (ERK) and to characterize the upstream signals leading to ERK activation in cardiomyocytes.

BACKGROUND

Because KBs attenuate K+ outward current, they may possibly prolong the duration of action potentials, leading to an increase in calcium (Ca2+) transient ([Ca2+]i) in cardiomyocytes. Elevation of intracellular Ca2+ levels can trigger various signaling events. Influx of Ca2+ through L-type Ca2+ channels after membrane depolarization induced activation of MEK and ERK through activation of Ras in neurons. Although KBs are frequently used to treat cardiac arrhythmias, their effect on signaling pathways remains unknown.

METHODS

Primary cultured rat cardiomyocytes were stimulated with four different KBs—4-aminopyridine (4-AP), E-4031, tetra-ethylammonium and quinidine—and phosphorylation of ERK, proline-rich tyrosine kinase 2 (Pyk2) and epidermal growth factor receptor (EGFR) was detected. Action potentials were recorded by use of a conventional microelectrode. (Ca2+)i was monitored by the fluorescent calcium indicator Fluo-4.

RESULTS

E-4031, 4-AP, tetra-ethylammonium and quinidine induced phosphorylation of ERK. 4-Aminopyridine prolonged the duration of action potentials by 37% and increased (Ca2+)i by 52% at 1 mmol/l. Pre-incubation of ethyleneglycoltetraacetic acid, 1,2-bis(2-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid tetrakis and diltiazem completely blocked this phosphorylation, whereas flufenamic acid and benzamil did not. 4-Aminopyridine induced tyrosine phosphorylation of Pyk2 and EGFR, which peaked at 5 and 10 min, respectively. Cytochalasin D, AG1478 and dominant-negative EGFR strongly inhibited the phosphorylation of ERK, whereas calphostin C, calmidazolium and KN62 did not.

CONCLUSIONS

These findings indicate that KBs induce ERK activation, which starts with Ca2+ entry through the L-type Ca2+ channel in cardiomyocytes, and that EGFR and Pyk2 are involved in this activation.

Abbreviations and Acronyms
  4-AP = 4-aminopyridine
  APD = action potential duration
  BAPTA-AM = 1,2-bis(2-aminophenoxy)-ethane- N,N,N',N'-tetraacetic acid tetrakis
  Ca2+ = calcium
  [Ca2+]i = Ca2+ transient
  EGFR = epidermal growth factor receptor
  ERK = extracellular signal-regulated kinase
  HA = hemaggulutinin
  K+ = potassium
  KB = potassium channel blocker
  LIF = leukemia inhibitory factor
  MAPK = mitogen-activated protein kinase
  MEK = MAPK/ERK kinase
  Na+ = sodium
  PKC = protein kinase C
  Pyk2 = proline-rich tyrosine 2
  TEA = tetra-ethylammonium




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
W.-Z. Ying, K. Aaron, and P. W. Sanders
Mechanism of dietary salt-mediated increase in intravascular production of TGF-{beta}1
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F406 - F414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. P. Frazier, A. Wilson, C. J. Dougherty, H. Li, N. H. Bishopric, and K. A. Webster
PKC-{alpha} and TAK-1 are intermediates in the activation of c-Jun NH2-terminal kinase by hypoxia-reoxygenation
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1675 - H1684.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S. M Gifford, F.-X. Yi, and I. M Bird
Pregnancy-enhanced store-operated Ca2+ channel function in uterine artery endothelial cells is associated with enhanced agonist-specific transient receptor potential channel 3-inositol 1,4,5-trisphosphate receptor 2 interaction.
J. Endocrinol., August 1, 2006; 190(2): 385 - 395.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. J. DOUGHERTY, L. A. KUBASIAK, D. P. FRAZIER, H. LI, W.-CHENG. XIONG, N. H. BISHOPRIC, and K. A. WEBSTER
Mitochondrial signals initiate the activation of c-Jun N-terminal kinase (JNK) by hypoxia-reoxygenation
FASEB J, July 1, 2004; 18(10): 1060 - 1070.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement